Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment

This publication has 41 references indexed in Scilit:

• Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade
  Neuropsychopharmacology, 2004
• The 5-HT2C receptor as a target for mood disorders
  Emerging Therapeutic Targets, 2004
• New approaches to developing antidepressants by enhancing monoaminergic neurotransmission
  Expert Opinion on Investigational Drugs, 2003
• Chronic Hypercortisolemia Inhibits Dopamine Synthesis and Turnover in the Nucleus accumbens: An in vivo Microdialysis Study
  Neuroendocrinology, 2002
• Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study
  International Clinical Psychopharmacology, 2002
• The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments
  Brain Research Reviews, 1997
• Nefazodone
  Drugs, 1997
• Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens
  Pharmacology Biochemistry and Behavior, 1995
• Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function
  Neuropharmacology, 1994
• Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
  International Clinical Psychopharmacology, 1994